nsc 181928 has been researched along with nocodazole in 4 studies
| Studies (nsc 181928) | Trials (nsc 181928) | Recent Studies (post-2010) (nsc 181928) | Studies (nocodazole) | Trials (nocodazole) | Recent Studies (post-2010) (nocodazole) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 3,078 | 0 | 655 |
| Protein | Taxonomy | nsc 181928 (IC50) | nocodazole (IC50) |
|---|---|---|---|
| Chain A, Glutathione-requiring prostaglandin D synthase | Homo sapiens (human) | 65 | |
| nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | 0.8334 | |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | 0.64 | |
| Tubulin alpha-1A chain | Sus scrofa (pig) | 1.3775 | |
| Tubulin beta chain | Sus scrofa (pig) | 0.76 | |
| Tubulin beta-4A chain | Homo sapiens (human) | 1.2975 | |
| Tubulin beta chain | Homo sapiens (human) | 1.2975 | |
| Tubulin alpha-3C chain | Homo sapiens (human) | 1.2975 | |
| Adenosine receptor A2a | Homo sapiens (human) | 7.509 | |
| Tubulin alpha-1B chain | Homo sapiens (human) | 1.2975 | |
| Tubulin alpha-4A chain | Homo sapiens (human) | 1.2975 | |
| Tubulin beta-4B chain | Homo sapiens (human) | 1.2975 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 6.232 | |
| Tubulin beta-3 chain | Homo sapiens (human) | 1.2975 | |
| Tubulin beta-2A chain | Homo sapiens (human) | 1.2975 | |
| Tubulin beta-8 chain | Homo sapiens (human) | 1.2975 | |
| Tubulin beta-2B chain | Bos taurus (cattle) | 2.3 | |
| Tubulin alpha-3E chain | Homo sapiens (human) | 1.2975 | |
| Tubulin alpha-1A chain | Homo sapiens (human) | 1.2975 | |
| Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | 2.3 | |
| Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | 2.3 | |
| Tubulin alpha-1C chain | Homo sapiens (human) | 1.2975 | |
| Tubulin beta-6 chain | Homo sapiens (human) | 1.2975 | |
| Tubulin beta-2B chain | Homo sapiens (human) | 1.2975 | |
| Tubulin beta-1 chain | Homo sapiens (human) | 1.2975 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Comber, RN; Elliott, RD; Kussner, CL; Montgomery, JA; Rose, JD; Temple, C; Wheeler, GP | 1 |
| Chi, DM; Hamel, E; Ho, HH; Shahrik, LK | 1 |
| Gupta, RS | 1 |
| Adamson, DJ; Bowdon, BJ; Temple, C; Webster, J; Wheeler, GP | 1 |
4 other study(ies) available for nsc 181928 and nocodazole
| Article | Year |
|---|---|
New anticancer agents: synthesis of 1,2-dihydropyrido[3,4-b]pyrazines (1-deaza-7,8-dihydropteridines).
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Folic Acid Antagonists; Leukemia L1210; Leukemia P388; Mice; Mitosis; Pyrazines; Pyridines | 1982 |
Tubulin-dependent hydrolysis of guanosine triphosphate as a screening test to identify new antitubulin compounds with potential as antimitotic agents: application to carbamates of aromatic amines.
Topics: Antineoplastic Agents; Benzimidazoles; GTP Phosphohydrolases; Guanosine Triphosphate; Hydrolysis; Mitosis; Nocodazole; Pyrazines; Quinazolines; Structure-Activity Relationship; Tubulin Modulators | 1989 |
Cross-resistance of nocodazole-resistant mutants of CHO cells toward other microtubule inhibitors: similar mode of action of benzimidazole carbamate derivatives and NSC 181928 and TN-16.
Topics: Animals; Benzimidazoles; Carbamates; Cell Line; Cricetinae; Drug Resistance; Female; Microtubules; Mutation; Nocodazole; Ovary; Podophyllotoxin; Pyrazines; Pyrrolidinones | 1986 |
Biological effects and structure-activity relationships of 1,2-dihydropyrido[3,4-b]pyrazines.
Topics: Animals; Benzimidazoles; Binding, Competitive; Cell Division; Cell Survival; Colchicine; Drug Synergism; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Mice; Nocodazole; Pyrazines; Structure-Activity Relationship; Tubulin; Vincristine | 1983 |